A startup that helps healthcare providers handle calls, texts and follow-ups with patients using AI has raised seed funding, Endpoints News learned exclusively. Gravity Rail

Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, but says its underlying performance remains strong.

Roche still has high sales hopes for its breast cancer pill giredestrant despite the drug’s failure in a first-line trial earlier this year. CEO Thomas

Sanofi’s new chief executive, Belén Garijo, will see her tenure at the company kick-started by a strong 2026 first quarter.

A UK-led bird flu vaccine trial has begun involving 4,000 volunteers as scientists prepare for the potential risk of a future influenza pandemic Supported by